Crossmark

Supramolecular nanoparticles self-assembled from reduction-responsive cabazitaxel prodrugs for effective cancer therapy

Crossref DOI link: https://doi.org/10.1039/D0CC06854C

Published Online: 2021

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Jin, Jiahui

Wan, Jianqin

Hu, Xiaoxiao

Fang, Tao

Ye, Zhijian

Wang, Hangxiang https://orcid.org/0000-0001-6370-9728
Funding

Funding for this research was provided by:

Zhejiang Provincial Natural Science Foundation of China (LR19H160002)

National Natural Science Foundation of China (81571799, 81773193, 82073296)

Jinhua Science and Technology Bureau (2017-3-020)

Zhejiang Province Public Welfare Technology Application Research Project (2017c37139)

Zhejiang University
License Information

Version of Record valid from 2021-01-15
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Hangxiang Wang (ORCID)

PEER REVIEW METHOD

: Authors can choose between single-blind and double-blind peer review

PUBLICATION HISTORY

: Received 14 October 2020; Accepted 15 January 2021; Accepted Manuscript published 15 January 2021; Advance Article published 3 February 2021; Version of Record published 2 March 2021